Humpback and minke whales are making their annual rounds near the shores of Newfoundland and Labrador, and one town on ...

Each time a cell divides, a small section of each chromosome's protective cap—the telomere—is worn away. Most cells use an ...

About CND261 CND261 is a bispecific antibody designed to target CD20 on B-cells and CD3 on T-cells, enabling T-cell mediated cytotoxicity against CD20-expressing B-cells.

A dual-target CAR T-cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing brain cancer. Tumors became smaller after the experimental CAR T-cell ...

More information: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial, Nature Medicine (2025). DOI: 10.1038/s41591-025-03745-0 ...

Justin Hayward doubts that the Moody Blues will return. The 'Nights in White Satin' group have been inactive since 2018 and Justin admits that it is difficult to see the band returning following ...

While CAR T cell therapy—a personalized form of cancer immunotherapy first successfully developed by Carl June, MD, and his team at Penn—has revolutionized treatment for many blood cancers ...

A version of this article appears in print on , Section D, Page 2 of the New York edition with the headline: Freaky Fashion: The ‘Bone Collector’ Doesn’t Play With Its Food.

Before cells are infused, however, patients receive a round of chemotherapy to deplete white blood cells and create an environment that is favorable for CAR T-cell expansion and survival. KYV-101 ...

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and predicts that a treatment could be approved in the next 5-10 years.

Session ID: 2025-07-06:9985144a9178309226fcbe5b Player Element ID: vjs_video_3 ...